decorative shape
patient advocacy strategies icon
Blog Posts

Tag: Operational Efficiency

Why Site Responsiveness Can Make or Break Recruitment

Why Site Responsiveness Can Make or Break Recruitment

The Fastest Way to Lose a Potential Participant Is to Make Them Wait Clinical trial recruitment discussions often focus on awareness, advertising, referral generation, and participant outreach. While these activities...

Published July 19, 2026
Why Recruitment Metrics Matter More Than Recruitment Volume

Why Recruitment Metrics Matter More Than Recruitment Volume

More Referrals Do Not Always Lead to More Enrollments Clinical trial recruitment is often measured by volume. How many referrals were generated? How many website visitors were captured? How many...

Published July 17, 2026
Trial Readiness Starts Before First Patient In

Trial Readiness Starts Before First Patient In

If You’re Waiting Until Recruitment Starts to Evaluate Readiness, You’re Already Behind Many sponsors treat trial readiness as a milestone achieved once sites are activated and recruitment materials are approved....

Published June 30, 2026
The Importance of Cross-Functional Alignment Before Study Launch

The Importance of Cross-Functional Alignment Before Study Launch

Most Study Launch Challenges Are Not Execution Problems When clinical trial enrollment falls behind projections, study sites struggle to keep pace, or recruitment vendors fail to deliver expected results, the...

Published June 28, 2026
How to Increase Clinical Trial Enrollment Without Increasing Headcount

How to Increase Clinical Trial Enrollment Without Increasing Headcount

Enrollment Challenges Are Often Operational Problems, Not Staffing Problems When enrollment falls behind plan, many organizations assume the solution is additional resources. More recruiters. More vendors. More advertising. More internal...

Published June 23, 2026
How Lean Biotech Teams Can Build Patient Engagement Capacity

How Lean Biotech Teams Can Build Patient Engagement Capacity

Patient Engagement Is No Longer Optional for Emerging Biotech Companies Emerging biotech companies face a difficult reality. Small teams are often responsible for clinical development, regulatory planning, investor expectations, study...

Published June 5, 2026
patient advocacy strategies icon
search...